Effects of interleukin-1β and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: A regional microdialysis study

Brain Research

Volumn 761, Issue 2, 1997, Pages 225-235

  Merali, Zul ^a   Lacosta, Susan ^b   Anisman, Hymie ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

Dopamine; Interleukin 1; Microdialysis; Norepinephrine; Rat; Serotonin

Indexed keywords

DOPAMINE; INTERLEUKIN 1BETA; NORADRENALIN; SEROTONIN; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; BIOGENIC AMINE; HOMOVANILLIC ACID; INTERLEUKIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HIPPOCAMPUS; IMMUNE FUNCTION TEST; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; AIR; ANIMAL; DRUG EFFECT; METABOLISM; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STRESS; SYNAPTIC TRANSMISSION;

3,4-DIHYDROXYPHENYLACETIC ACID; AIR MOVEMENTS; ANIMALS; BIOGENIC MONOAMINES; DOPAMINE; HIPPOCAMPUS; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; INTERLEUKIN-1; MALE; METHOXYHYDROXYPHENYLGLYCOL; MICRODIALYSIS; NOREPINEPHRINE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STRESS; SYNAPTIC TRANSMISSION;

EID: 0030610360     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00312-0     Document Type: Article

References (64)

1. E.D. Abercrombie, K.A. Keefe, D.S. DiFrischia, M.J. Zigmond, Differential effects of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex, J. Neurochem. 52 (1989) 1655-1658.
2. Anisman, H., Zalcman, S., Shanks, N. and Zacharko, R.M., Multi-system regulation of performance deficits induced by stressors: an animal model of depression. In A. Boulton, G. Baker and M. Martin-Iverson (Eds.), Neuromethods, Vol. 19: Animal Models of Psychiatry, II, Humana Press, NJ, 1991, pp. 1-59.
3. H. Anisman, S. Zalcman, R.M. Zacharko, The impact of stressors on immune and central neurotransmitter activity: bidirectional communication, Rev. Neurosci. 4 (1993) 147-180.
4. B.M. Araujo, P.A. Lapchak, B. Collier, R. Quirion, Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system, Brain Res. 498 (1989) 257-266.
5. E. Ban, C. Marquette, A. Sarrieau, F. Fitzpatrick, G. Fillion, G. Milon, W. Rostene, F. Haour, Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids, Neuroendocrinology 58 (1993) 581-587.
6. W.A. Banks, A.J. Kastin, D.A. Durham, Bidirectional transport of interleukin-1 alpha across the blood-brain barrier, Brain Res. Bull. 23 (1989) 433-437.
7. H. Benveniste, Brain microdialysis, J. Neurochem. 49 (1987) 729-734.
8. F. Berkenbosch, D.A.W. Wolvers, R. de Rijk, Neuroendocrine and immunological mechanisms in stress-induced immunomodulation, J. Steroid Biochem. Mol. Biol. 40 (1991) 639-647.
9. Besedovsky, H.O. and Del Rey, A., Physiological implications of the immune-neuro-endocrine network. In R. Ader, D.L. Felten and N. Cohen (Eds.), Psychoneuroimmunology, Academic Press, San Diego, CA, 1991, pp. 589-608.
10. H.O. Besedovsky, E. Sorkin, D. Felix, H. Haas, Hypothalamic changes during the immune response, Eur. J. Immunol. 7 (1977) 325-328.
11. H.O. Besedovsky, A. Del Rey, E. Sorkin, M. Da Prada, R. Burri, C. Honegger, The immune response evokes changes in brain noradrenergic neurons, Science 221 (1983) 564-566.
12. J.E. Blalock, The immune system as a sensory organ, J. Immunol. 132 (1984) 1067-1070.
13. J.E. Blalock, The syntax of immune-endocrine communication, Immunol. Today 15 (1994) 504-544.
14. L.S. Brady, A.B. Lynn, M. Herkenham, Z. Gottesfeld, Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain, J. Neurosci. 14 (1994) 4951-4964.
15. S.L. Carlson, D.L. Felten, S. Livnat, S.Y. Felten, Alterations of monoamines in specific central autonomic nuclei following immunization in mice, Brain Behav. Immun. 1 (1987) 52-63.
16. M.F. Dallman, S.F. Akana, M.J. Bradbury, A.M. Strack, E.S. Hanson, K.A. Scribner, Regulation of the hypothalamo-pituitary-adrenal axis during stress: feedback, facilitation and feeding, Semin. Neurosci. 6 (1994) 205-213.
17. R. Dantzer, K.W. Kelley, Stress and immunity: an integrated view of relationships between the brain and the immune system, Life Sci. 44 (1989) 1995-2008.
18. J.F.W. Deakin, F.G. Graeff, F.S. Guimaraes, Microdialysis studies with 5-HT reuptake inhibitors. Reply, Trends Pharmacol. Sci. 14 (1993) 398.
19. A.Y. Deutch, R.H. Roth, The determinants of stress-induced activation of the prefrontal cortical dopamine system, Prog. Brain Res. 85 (1990) 367-403.
20. A.Y. Deutch, S.-Y. Tam, R.H. Roth, Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra, Brain Res. 333 (1985) 143-146.
21. A.J. Dunn, Nitric oxide synthase inhibitors prevent the cerebral tryptophan and serotonergic responses to endotoxin and interleukin-1, Neurosci. Res. Commun. 13 (1993) 149-156.
22. A.J. Dunn, Interleukin-1 as a stimulator of hormone secretion, Prog. Neuroendocr. Immunol. 3 (1990) 26-34.
23. A.J. Dunn, Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone, Life Sci. 43 (1988) 429-435.
24. A.J. Dunn, J. Welch, Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity, J. Neurochem. 57 (1991) 1615-1622.
25. A.J. Dunn, M.L. Powell, C. Meitin, P.A. Small, Virus infection as a stressor: influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of MHPG and tryptophan, Physiol. Behav. 45 (1989) 591-594.
26. A.J. Dunn, M.L. Powell, W.V. Moreshead, J.M. Gaskin, N.R. Hall, Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation, Brain Behav. Immun. 1 (1987) 216-230.
27. A. Ericsson, J.K. Kovacs, P.E. Sawchenko, A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons, J. Neurosci. 14 (1994) 897-913.
28. W.L. Farrar, P.L. Kilian, M. Ruff, J.M. Hill, C.B. Pert, Visualization and characterization of interleukin-1 receptors in brain, J. Immunol. 139 (1987) 459-463.
29. Fibiger, H.C., Neurobiology of depression: focus on dopamine. In G. Gessa, W. Fratta, L. Pani and G. Serra (Eds.), Depression and Mania: from Neurobiology to Treatment, Raven Press, New York, 1995, pp. 1-17.
30. A.M. Gardier, S. Kachaner, E.K. Shaghaghi, C. Blot, C. Bohuon, C. Jacquot, M.J. Pallardy, Effects of a primary immune response to T-cell dependent antigen on serotonin metabolism in frontal cortex: in vivo microdialysis study in freely moving Fischer 344 rat, Brain Res. 645 (1994) 150-156.
31. F. Haour, C. Marquette, E. Ban, M. Crumeyrolle-Arias, W. Rostene, H. Tsiang, G. Fillion, Receptors for interleukin-1 in the central nervous and endocrine systems, Ann. Endocrinol. 56 (1995) 173-179.
32. S.J. Hopkins, N.J. Rothwell, Cytokines and the nervous system I. Expression and recognition, Trends Neurosci. 18 (1995) 83-88.
33. H. Imura, J.-I. Fukata, T. Mori, Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems, Clin. Endocrinol. 35 (1991) 107-115.
34. A. Kabiersch, A. Del Rey, C.G. Honegger, H.O. Besedovsky, Interleukin-1 induces changes in norepinephrine metabolism in the rat brain, Brain Behav. Immun. 2 (1988) 267-274.
35. G. Katsuura, P.E. Gottschall, A. Arimura, Identification of a high-affinity receptor for interleukin-1 beta in rat brain, Biochem. Biophys. Res. Commun. 156 (1988) 61-67.
36. J.I. Koenig, Presence of cytokines in the hypothalamic-pituitary axis, Prog. Neuroendocr. Immunol. 4 (1991) 143-153.
37. S. Lacosta, Z. Merali, S. Zalcman, H. Anisman, Time-dependent in vivo mesolimbic dopamine variations following antigenic challenge, Brain Res. 664 (1994) 225-230.
38. S. Lacosta, Z. Merali, H. Anisman, Cytokine-induced endocrine, neurochemical and behavioral alterations, Soc. Neurosci. Abst. 21 (1995) 1397.
39. P.A. Lapchak, A role for interleukin-2 in the regulation of striatal dopaminergic function, Neuroreport 3 (1992) 165-168.
40. A.C.E. Linthorst, C. Flachskamm, P. Muller-Preuss, F. Holsboer, J.M.H.M. Reul, Effect of bacterial endotoxin and interleukin-1 β on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study, J. Neurosci. 15 (1995) 2920-2934.
41. S.F. Maier, L.R. Watkins, Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock, Brain Res. 695 (1995) 279-282.
42. M.I. Masana, M.P. Heyes, I.N. Mefford, Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge, Prog. Neuro-Psychopharmacol. Biol. Psychiat. 14 (1990) 609-621.
43. I.N. Mefford, M.P. Heyes, Increased biogenic amine release in mouse hypothalamus following immunological challenge: antagonism by indomethacin, J. Neuroimmunol. 27 (1990) 55-61.
44. P.S. Mohankumar, S. Thyagarajan, S.K. Quadri, Interleukin-1 β increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo, Brain Res. Bull. 31 (1993) 745-748.
45. P.S. Mohankumar, S. Thyagarajan, S.K. Quadri, Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from hypothalamus in vivo, Life Sci. 48 (1991) 925-930.
46. G. Nistico, G. De Sarro, Is interleukin 2 a neuromodulator in the brain?, Trends Neurosci. 14 (1991) 146-150.
47. P.E. Paulson, T.E. Robinson, Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats, Synapse 19 (1995) 56-65.
48. Paxinos, G. and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates, Academic Press, New York.
49. C.R. Plata-Salaman, Immunoregulators in the nervous system, Neurosci. Biobehav. Rev. 15 (1991) 185-215.
50. B.S. Rabin, S. Cohen, R. Ganguli, D.T. Lysle, J.E. Cunnick, Bidirectional interaction between the central nervous system and the immune system, Crit. Rev. Immunol. 9 (1989) 279-312.
51. S. Rivest, C. Rivier, The role of corticotropin-releasing factor and interleukin-1 in the regulation of neurons controlling reproductive functions, Endocr. Rev. 16 (1995) 177-199.
52. C. Rivier, Effect of peripheral and central cytokines on the hypothalamic-pituitary-adrenal axis of the rat, Ann. NY Acad. Sci. 697 (1993) 97-105.
53. Rivier, C., Role of endotoxin and interleukin-1 in modulating ACTH, LH and sex steroid secretion. In J.C. Porter and D. Jezova (Eds.), Circulating Regulatory Factors and Neuroendocrine Function, Plenum, New York, 1990, pp. 295-302.
54. N.J. Rothwell, S.J. Hopkins, Cytokines and the nervous system II. Actions and mechanisms of action, Trends Neurosci. 18 (1995) 130-136.
55. N. Shanks, D. Francis, S. Zalcman, M.J. Meaney, H. Anisman, Alterations of central catecholamines associated with immune responding in adult and aged mice, Brain Res. 666 (1994) 77-87.
56. B. Schobitz, E.R. De Kloet, F. Holsboer, Gene expression and function of interleukin-1, interleukin-6 and tumor necrosis factor in the brain, Prog. Neurobiol. 44 (1992) 397-432.
57. F. Shintani, S. Kanba, T. Nakaki, M. Nibuya, N. Kinoshita, E. Suzuki, G. Yagi, R. Kato, M. Asai, Interleukin-1 β augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus, J. Neurosci. 13 (1993) 3574-3581.
58. F. Shintani, T. Nakaki, S. Kanba, K. Sato, G. Yagi, M. Shiozawa, S. Aiso, R. Kato, M. Asai, Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat, J. Neurosci. 15 (1995) 1961-1970.
59. L.R. Watkins, S.F. Maier, L.E. Goehler, Cytokine-to-brain communication: a review and analysis of alternative mechanisms, Life Sci. 57 (1995) 1011-1026.
60. B.H.C. Westerink, Brain microdialysis and its application for the study of animal behaviour, Behav. Brain Res. 70 (1995) 103-124.
61. P.T.-H. Wong, W.L. Teo, T. Lee, A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine, Neuroreport 5 (1993) 53-56.
62. S. Zalcman, N. Shanks, H. Anisman, Time-dependent variations of central norepinephrine and dopamine following antigen administration, Brain Res. 557 (1991) 69-76.
63. S. Zalcman, J. Green-Johnson, L. Murray, D.M. Nance, D. Dyck, H. Anisman, A. Greenberg, Cytokine-specific central monoamine alterations induced by interleukin (IL)-1, IL-2 and IL-6, Brain Res. 643 (1994) 40-99.
64. T. Zetterstrom, T. Sharp, A.K. Collin, U. Ungerstedt, In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC, Eur. J. Pharmacol. 148 (1988) 327-334.